![News](https://firebrickpharmabucket.s3.ap-southeast-2.amazonaws.com/wp-content/uploads/2021/11/23084701/hero-banner.jpg)
Posts Tagged ‘Firebrick Pharma’
Nasodine trial in COVID-19 started
26 Apr 2022
Firebrick Pharma is pleased to announce that the Phase 2 COVID-19 clinical trial for Nasodine® Nasal Spray (“Nasodine”) in South Africa has commenced, with the first patient now recruited.